Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART) – A study protocol for an open-label, phase II, multicenter study
Author:
Funder
Chugai Pharmaceutical
Japan Society for the Promotion of Science
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference48 articles.
1. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project;Hori;Jpn. J. Clin. Oncol.,2015
2. Asia consensus statement on NCCN clinical practice guideline for bladder cancer;Nishiyama;Jpn. J. Clin. Oncol.,2018
3. Muscle-invasive bladder cancer: evaluating treatment and survival in the national cancer data base;Smith;BJU Int.,2014
4. Bladder preservation therapy: review of literature and future directions of trimodal therapy;El-Achkar;Curr. Urol. Rep.,2018
5. Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy;Schrier;Eur. Urol.,2004
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and Safety of Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Interim Analysis from a Multicenter, Open-label, Prospective Phase 2 Trial;International Journal of Radiation Oncology*Biology*Physics;2023-11
2. The Current Progress and Future Options of Multiple Therapy and Potential Biomarkers for Muscle-Invasive Bladder Cancer;Biomedicines;2023-02-13
3. Efficacy of long-term extended nursing services combined with atezolizumab in patients with bladder cancer after endoscopic bladder resection;Medicine;2022-09-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3